> Investors > 

News Releases

Date Title  
Toggle Summary ACETO Completes the Sale of Its Chemicals Business Assets
PORT WASHINGTON, N.Y. , April 30, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital , a leading growth-oriented investment firm with over $20 billion in
Printer Friendly Version
Toggle Summary ACETO Completes the Sale of Rising Pharmaceuticals
PORT WASHINGTON, N.Y. , April 22, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has completed
Printer Friendly Version
Toggle Summary ACETO to Sell its Chemicals Business Assets to New Mountain Capital
PORT WASHINGTON, N.Y. , April 15, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has agreed to sell
Printer Friendly Version
Toggle Summary ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc.
PORT WASHINGTON, N.Y. , April 12, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (OTC: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received
Printer Friendly Version
Toggle Summary ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals
PORT WASHINGTON, N.Y. , March 07, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into
Printer Friendly Version
Toggle Summary ACETO Announces Receipt of Nasdaq Notice Due to Delay in Filing Form 10-Q for the Fiscal Quarter Ended December 31, 2018
PORT WASHINGTON, N.Y. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it received a
Printer Friendly Version
Toggle Summary ACETO Announces Proposed Sale of its Chemicals Business Assets to New Mountain Capital for $338 million
ACETO and its U.S. Subsidiaries File Voluntary Chapter 11 Petitions to Facilitate Sale Secures Commitment for Debtor-in-Possession Financing to Support Normal Course Operations ACETO Pursuing Court-Supervised Sale of Rising Pharmaceuticals PORT WASHINGTON, N.Y. , Feb.
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2019 First Quarter Results
PORT WASHINGTON, N.Y. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the
Printer Friendly Version
Toggle Summary ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits
PORT WASHINGTON, N.Y. , Nov. 05, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) today announced that its Board of Directors has adopted a tax asset protection rights plan (the “Rights Plan”).  The Rights Plan is designed to preserve ACETO’s net operating loss carryforwards (NOLs) and
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules First Quarter & Fiscal 2019 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
top